Injured by Valsartan?
FREE CASE REVIEW
FREE CASE REVIEW
If you or a loved one have taken Valsartan and experience one or more of the following side effects, contact our Valsartan Injury Attorneys today to find out if you have a case!
NOTICE: In 2018, the US Food and Drug Administration (FDA) began a recall of certain valsartan products due to the presence of a dangerous ingredient known to cause cancer. The cancer-causing contaminants are known as N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA).
What the FDA Says:
As these contaminated products were in distribution for at least four years, many patients were consistently exposed to these carcinogenic chemicals and are now having health issues.
What Scientists Are Saying:
These carcinogens increased the risk of cancer and kidney or liver damage for each patient taking the contaminated batches of valsartan. A recent study has specifically linked colorectal and uterine cancers to the contaminated valsartan.
What We Stand For:
You’re more than just a patient. You’re a person, with a family, a house, and a career. You’ve spent your life working hard toward your goals and (one day) a healthy retirement. But due to the carelessness of a big pharmaceutical company, you may have been robbed of your future.
Our attorneys are experienced with complex medical cases. Help is just a phone call away.
Note: If you or a loved one is taking valsartan, continue taking the medication even if you believe your medication has been affected by the recall, due to the significant risk of heart attack and stroke by not taking the medication. Speak with your prescribing doctor immediately for an alternative prescription and contact us to discuss your case as you may be entitled to compensation for your pain and medical bills .
Valsartan is an oral medication prescribed primarily for high blood pressure.
Valsartan is used to treat heart failure, high blood pressure, enhance kidney function, and help lower the risk of dying from a heart attack.
Valsartan is a generic version of Diovan, an antihypertensive drug created by Novartis International AG. Valsartan is manufactured and distributed by a number of pharmaceutical companies such as Alembic Pharmaceuticals Ltd., Novel Laboratories Inc., Unichem Pharmaceuticals, Teva Pharmaceuticals, Major Pharmaceuticals, and SolCo Healthcare.
Doctors, cardiologists, and medical specialists prescribe valsartan for the treatment of high blood pressure and patients at risk of heart failure. Valsartan is usually prescribed following a heart attack or those at risk of death from congestive heart failure, a condition that usually develops following a heart attack.
Valsartan and its non-generic form Diovan require a doctor’s prescription and pickup at a local pharmacy. Valsartan may be available online, but patients should exercise caution before purchasing online as the supplier could be overseas or less reputable.
When taking valsartan, patients typically receive the following instructions:
Numerous studies have shown the effectiveness of antihypertensive drugs such as valsartan in reducing cardiovascular disease or complications directly related to heart failure. Valsartan, along with other antihypertensive drugs used to treat high blood pressure, should be used in conjunction with a cardiovascular risk management plan to enhance its effectiveness and potentially resolve the issue so the patient can reduce or stop taking valsartan.
A cardiovascular risk management plan entails:
Antihypertensive drugs are given not only to help high blood pressure, but may also be prescribed to reduce the risk of:
Some of the more common side effects of valsartan include:
There are some severe side effects associated with valsartan that warrant immediate medical attention. Seek help right away if you experience any of the following:
The contaminants found in recalled valsartan can cause both kidney and liver damage, as well as a few types of cancer.
However, uncontaminated valsartan prescribed in the proper doses and combined with a cardiovascular risk management plan may help protect kidneys for high-risk patients, according to a study published in the Anatolian Journal of Cardiology.
The FDA recalled certain valsartan and valsartan HCTZ medications in 2018, after finding dangerous cancer-causing contaminants called NMDA and NDEA. In the United States, numerous pharmaceutical companies are liable, but the contaminants were traced back to an overseas manufacturer by the name of Zhejiang Huahei Pharmaceuticals.
Patients that were directly affected by the faulty drugs may be entitled to compensation for their pain and medical bills with a number of class action lawsuits currently reaching courts. Contact our legal team today for a free consultation and personal insight on how to join one of these class action lawsuits.
The FDA investigation revealed the impurity or byproduct was likely introduced during the manufacturing process. In the United States, valsartan manufacturers or suppliers that sourced ingredients from the Chinese company Zhejiang Huahai Pharmaceuticals have been identified. In some cases, it appears these companies were aware of the issue or could have prevented it.
First reports of patients experiencing health problems related to the recalled valsartan products surfaced in 2015. These patients were diagnosed with liver, kidney, or intestine problems, with some experiencing organ damage and developing liver or kidney cancer. The contaminants, NMDA and NDEA, have been classified as carcinogens since 2005.
The following is a list that covers the individual suppliers and drugs affected by recalls. However, for more detailed information regarding lot number and expiration dates on the affected drugs, please download the FDA’s regularly-updated valsartan list here.
A-S Medication Solutions LLC
Bryant Ranch Prepack Inc.
Hetero Labs, Inc./Camber Pharmaceuticals, Inc.
NuCare Pharmaceuticals Inc.
Preferred Pharmaceuticals, Inc.
Pharma Pac (Prinston/Solco)
Solco Healthcare/Prinston Pharmaceuticals
Valsartan that is contaminated with the chemicals NDMA or NDEA has been linked to severe kidney and liver damage, including increased risk of:
A 2018 Danish study published in the British Medical Journal (BMJ) looked into the direct link between the contaminated NDMA valsartan products and the increased risk of cancer. This study followed 5150 people for an average of 4.6 years. During that time, there were 104 incidents of cancer in the group not exposed to the contaminants in valsartan. The group that was exposed to NDMA was cited at 198 incidents of cancer. For single cancer incidents specifically, colorectal cancer and uterine cancer both had increased rates.
If you or a loved one is currently taking Valsartan, here are some important points to consider:
If you are concerned about future risk with taking any antihypertensive medication, speak with your doctor or trained medical professional to create a cardiovascular risk management plan.
If you or a loved one is taking valsartan and believe your medication was part of the recall, contact your prescribing doctor immediately to change your prescription. However, don’t suddenly stop taking antihypertensive medication without any medical supervision due to the increased risk of heart attack and stroke.
Cancer can take a long time to develop, but you need immediate steps on what to do next. Here’s a guideline of what you can do if you were part of the valsartan recall:
1. Contact your prescribing doctor immediately to change your prescription. If you’d like to reduce your need for this prescription, consider speaking with your doctor about creating a cardiovascular risk management plan.
2. Schedule a check-up with your primary care provider to assess potential liver or kidney damage. Request comprehensive bloodwork to check for early warning signs of cancer.